Liberman et al., 2011 - Google Patents
Use of soy peptones for Streptococcus pneumoniae cultivation for vaccine productionLiberman et al., 2011
View PDF- Document ID
- 581981554599281263
- Author
- Liberman C
- Kolling D
- Sari R
- Takagi M
- Cabrera-Crespo J
- Sbrogio Almeida M
- Pradella J
- Leite L
- Gonçalves V
- Publication year
- Publication venue
- Soybeans: cultivation, uses and nutrition. Nova Science Publishers, Hauppauge
External Links
Snippet
ABSTRACT S. pneumoniae is a pathogen that affects the human respiratory tract, causing otitis media, sinusitis, pneumonia, meningitis and sepsis. Pneumococcus is a fastidious anaerobic fermentative microorganism that produces mainly lactate. S. pneumoniae …
- 238000004519 manufacturing process 0 title abstract description 38
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases Endopeptidases (3.4.21-3.4.25) derived from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—PROCESSES USING MICRO-ORGANISMS
- C12R1/00—Processes using micro-organisms
- C12R1/01—Processes using micro-organisms using bacteria or actinomycetales
- C12R1/46—Streptococcus; Enterococcus; Lactococcus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—PROCESSES USING MICRO-ORGANISMS
- C12R1/00—Processes using micro-organisms
- C12R1/01—Processes using micro-organisms using bacteria or actinomycetales
- C12R1/07—Bacillus
- C12R1/125—Bacillus subtilis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6925280B2 (en) | Akkermansia culturing method | |
| CN103687612B (en) | Process for detergent-free production of outer membrane vesicles | |
| US8900594B2 (en) | Oral recombinant Helicobacter pylori vaccine and preparing method thereof | |
| Head et al. | Purification and characterization of verocytotoxin 2 | |
| CN102596239A (en) | Immunogenic composition comprising antigenic S. aureus proteins | |
| Goncalves et al. | Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability | |
| US9526775B2 (en) | Glycoengineered outer membrane vesicles and use thereof as vaccines | |
| WO2011151841A1 (en) | Fermentation process for streptococcus pneumoniae | |
| Gonçalves et al. | Optimization of medium and cultivation conditions for capsular polysaccharide production by Streptococcus pneumoniae serotype 23F | |
| JP2595133B2 (en) | Immunostimulant and method for producing the same | |
| CN113329766A (en) | Clostridium difficile multicomponent vaccine | |
| US8557537B2 (en) | Method for the production of overproducing Staphylococcus aureus strains | |
| CN111836883B (en) | Bacillus genus bacteria, interleukin-22 production inducer, skin barrier function enhancer | |
| Liberman et al. | Use of soy peptones for Streptococcus pneumoniae cultivation for vaccine production | |
| KR102028693B1 (en) | Method for manufacturing of Streptococcus pneumonia capsule polysaccharide | |
| CN101608201A (en) | A kind of production method of novel Streptococcus thermophilus bacteriocin | |
| Gogola-Kolling et al. | Improved capsular polysaccharide production by Streptococcus pneumoniae serotype 14 using continuous cultivation | |
| KR100649286B1 (en) | Vaccine preparations containing supernatant toxin | |
| Campos et al. | Process intensification for production of Streptococcus pneumoniae whole‐cell vaccine | |
| KR102047911B1 (en) | Inactivated Vaccine Against Streptococcal Disease in Fish, Preparing Method Thereof and Administrating Method Thereof | |
| KR102106168B1 (en) | Combination Vaccines Against Streptococcal Disease in Fish | |
| RU2098127C1 (en) | Mixed vaccine for control over cattle necrobacteriosis | |
| US9132183B2 (en) | Modified live (JMSO strain) Haemophilus parasuis vaccine | |
| Jin et al. | Optimization of capsular polysaccharide production by Streptococcus pneumoniae type 3 | |
| KR20100030729A (en) | Culture medium for production of capsular polysaccharide from streptococcus sp., process for production thereof, and process for purification thereof |